Los Angeles-based Kythera Biopharmaceuticals, which is developing products for the aesthetic medicine market, disclosed this morning that it has received $10M as part of the firm's Series C funding round. According to Kythera, the round included all of its existing investors, including Versant Ventures, ARCH Venture Partners, Prospect Venture Partners, BBT Capital Management/Apothecary Capital, JAFCO, PFM, and Altitude Life Science Ventures. The firm said that the round was part of a $40M, Series C financing round, which the firm had announced in 2008. Kythera said that the investment increases the firm's financial strength, and will go towards clinical development of its products.
Top NewsWednesday, February 18, 2009
Kythera Biopharmaceuticals Lands $10M